Clinical trial NCT06760689: Brief Title- Virtual Reality Glasses in Gynecologic Cancer
Official title: The Effect of Virtual Reality Glasses Used in Gynecologic Cancer Patients Receiving Chemotherapy on Treatment Compliance and Anxiety Level.
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: NA
Conditions: Gynecologic Cancers
Anxiety
Keywords: Anxiety
chemotherapy
Gynecological cancer
Virtual reality
Adherence to treatment
rastgele kontrollü deneme
Lead sponsor: Çankırı Karatekin University
Sponsor class: OTHER
First posted: 2025-01-07
Enrollment: 118
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 65
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: The study has a single-center, randomized controlled experimental design. It includes the experimental and control group.
Primary purpose: SUPPORTIVE_CARE

Brief summary: It was planned to determine the effect of virtual reality glasses used in female patients diagnosed with gynecological cancer and receiving chemotherapy on treatment compliance and anxiety level. The study has a single-center, randomized controlled experimental design.

Detailed description: When cancer is diagnosed, a process of uncertainty begins for the individual. When an individual associates their illness with death, they often consider the situation to be frightening, painful, complex, and ambiguous, which can lead to mental confusion. ). In these emotional fluctuations, studies have revealed that a large proportion of patients experience various mental problems such as anxiety and anxiety disorders, coordination disorders and adherence to treatment, both due to the burden of the disease and the side effects of treatment. Emotional negativities felt by the patient may cause the recovery process to be prolonged, the quality of life to decrease, and the length of hospital stay to increase when in a hospital environment. In order to prevent such negativities, it is very important to identify the symptoms of anxiety and depression in cancer patients at an early stage and to initiate appropriate treatments. The development and application of the latest technology in the field of health offers new and non-invasive approaches to cancer-related symptom management. Virtual reality (SG), a new era in the management of symptoms, is the combination of fiction, imagination and reality, which is capable of real reflective animation at the same time under the control of many devices. Virtual reality (SG), a new era in the management of symptoms, is the combination of fiction, imagination and reality, which is capable of real reflective animation at the same time under the control of many devices.In a clinical study, it was concluded that distracting videos (tennis, boxing video, etc.) watched with virtual reality glasses had a beneficial therapeutic effect on edema.As a result of the one-week virtual reality application awareness training conducted on 50 women with ovarian cancer who experienced anxiety, depression and cancer-related fatigue during chemotherapy in Beijing, China, it was recorded that these symptoms improved significantly.When the literature was reviewed, it was predicted that the application of virtual reality glasses in cancer patients in our country was limited, and this study was planned to determine the effect of virtual reality glasses used in female patients diagnosed with gynecological cancer and receiving chemotherapy on the level of compliance and anxiety.

Eligibility criteria: Inclusion Criteria:

* Being over 18 years old.
* Stage 1-2-3
* Knowing the disease diagnosis
* Knowing how to read and write in Turkish
* No history of seizures
* No cranial metastasis
* Not diagnosed with a psychiatric disorder, no dementia
* Those who receive their treatment in 21-day periods to ensure equality in application frequencies
* Able to use virtual reality glasses
* No visual or hearing impairment
* Volunteer patients

Exclusion Criteria:

* Stage 4
* Those with vertigo
* Those with hyperemesis during pregnancy
* Those who experience nausea and vomiting during travel
* Those with visual and hearing impairment
* Patients who do not know their cancer diagnosis, have been diagnosed with cancer but have not received treatment or have completed their cure

Primary outcomes:
measure: Effect of Virtual Reality Glasses on Treatment Adherence and Anxiety Levels in Gynecological Cancer Patients Receiving Chemotherapy.
timeFrame: 20 weeks
measure: State and trait anxiety scale
timeFrame: 20 weeks
measure: Chronic Disease Adjustment Scale
timeFrame: 20 weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Ankara
country: Turkey
facility: Etlik Şehir Hastanesi
state: Yenimahalle
Study officials:
References: